Cytosorbents Corp (CTSO) Balance Sheet
As of 2026-06-30 (10-Q), Cytosorbents Corp (CTSO) reported total assets of $38.0M, total liabilities of $38.7M and shareholders' equity of -$751000, according to EquiReason's reading of its SEC filings. Cash and equivalents: $4.4M. Long-term debt: $3.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CTSOCytosorbents CorpFollow CTSO — free
—
Price chart with a free account
- Market cap
- 16.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.2 | 1.7 | 2.2 | 3.6 | 5.3 | 5.2 | 17.3 | 22.4 | 12.2 | 71.4 | 52.1 | 22.1 | 14.1 | 3.3 | 6.2 | 4.4 | |
| Short-term investments | — | — | — | 1.9 | 2.2 | 0.0 | — | — | — | — | — | — | — | — | — | — | |
| Receivables | 0.0 | — | — | 0.8 | 0.6 | 1.4 | 2.2 | 3.9 | 4.5 | 5.2 | 4.5 | 5.7 | 6.1 | 7.3 | 7.6 | 6.8 | |
| Inventory | 0.4 | 0.7 | 0.2 | 0.5 | 1.2 | 0.8 | 0.8 | 0.8 | 2.1 | 2.7 | 4.8 | 3.5 | 3.4 | 2.7 | 5.3 | 3.7 | |
| Current assets | 1.7 | 2.9 | 3.5 | 7.6 | 9.9 | 7.8 | 20.7 | 28.3 | 20.9 | 82.5 | 64.3 | 33.8 | 25.4 | 21.6 | 20.6 | 15.7 | |
| Total assets | 2.1 | 3.3 | 4.0 | 8.5 | 11.3 | 9.7 | 24.1 | 34.2 | 27.4 | 90.0 | 89.5 | 63.2 | 53.0 | 47.4 | 44.2 | 38.0 | |
| Current liabilities | 1.5 | 2.1 | 3.1 | 4.5 | 3.0 | 4.3 | 7.8 | 6.9 | 9.9 | 10.2 | 13.7 | 9.7 | 14.0 | 9.8 | 9.7 | 24.0 | |
| Long-term debt | — | 0.9 | 1.6 | — | 0.0 | 4.1 | 6.0 | 9.3 | 13.4 | 0.0 | — | 5.0 | 2.5 | 14.0 | 16.7 | 3.1 | |
| Short-term debt | 0.3 | 0.9 | 1.6 | — | 0.0 | 0.8 | 4.0 | 0.7 | 1.7 | 0.0 | — | — | 2.5 | — | — | 14.1 | |
| Total liabilities | 1.8 | 2.1 | 3.1 | — | 3.0 | 8.4 | 13.8 | 17.3 | 24.0 | 10.7 | 26.9 | 27.9 | 29.5 | 36.3 | 38.3 | 38.7 | |
| Shareholders' equity | -10.1 | -11.6 | -14.3 | 6.9 | 9.8 | 1.3 | 10.3 | 16.9 | 3.4 | 79.2 | 62.6 | 35.4 | 23.5 | 11.1 | 5.9 | -0.8 |
USD millions · SEC XBRL
Cytosorbents Corp — questions
- How much cash does Cytosorbents Corp have?
- $4.4M in cash and cash equivalents as of 2026-06-30.
- How much debt does Cytosorbents Corp have?
- $3.1M of long-term debt and $14.1M due within a year as of 2026-06-30.
- What are Cytosorbents Corp's total assets?
- $38.0M as of 2026-06-30.
- What is Cytosorbents Corp's shareholders' equity?
- -$751000 as of 2026-06-30.
Every figure on this page comes from Cytosorbents Corp's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.